With the aim of finding a correlation between the crystallization kinetics and the molecular dynamics of a substance that would allow to predict its crystallization time as a function of temperature for a given α relaxation time, we have studied Stiripentol, an anticonvulsant drug. Stiripentol has been characterized in its supercooled liquid, amorphous (glass) and crystalline states by the concurrent use of Broadband Dielectric Spectroscopy (BDS), differential scanning calorimetry, x-ray diffraction and optical microscopy. BDS was employed to study both the dipolar molecular dynamics and the kinetics of crystallization from the melt. Three different molecular relaxation dynamics were identified: an α relaxation corresponding to the collective reorientation of the molecules and associated with the glass transition (T g = 246.2 ± 0.5 K), a Johari * To whom correspondence should be addressed † Grup de Caracterització de Materials ‡ Barcelona Research Center in Multiscale Science and Engineering
Introduction
Active pharmaceutical ingredients (API's) are generally stored in solid form, either as crystalline or amorphous (glassy) powders. [1] [2] [3] The amorphous form of API's, though being thermodynamically unstable, 4,5 offers some advantages: amorphous phases show more solubility and better dissolution profiles and hence better bioavailability than crystal phases, by virtue of their higher free energy. 6-9 It has also been reported that in some cases amorphous drugs can be compacted into tablets more effectively than polycrystalline powders, even omitting the addition of excipients. 10 By means of formulation in amorphous phase, many drugs with originally poor aqueous solubility have reached the drug development stage during the last decade. [11] [12] [13] Although the detailed microscopic mechanisms governing the kinetic stability of amorphous API's remain unknown, the crystallization kinetics appears to be determined by a large number of factors such as preparation method, thermal and mechanical treatments employed during formulation, storage temperature, application of pressure, or exposure to humidity. 14, 15 It is then of utter importance to find out which are the mechanisms taking place in the amorphous to crystalline transformation, so as to be able to find optimum production and storage conditions of the formulated drug.
16-22
Many factors are involved in the stability of a substance. Thermodynamic quantities such as differences in free energy between the phases involved and interfacial energies, play a role as they determine the stable phase of the system and the energetic cost of having a mixed-phase sample. However, thermodynamic quantities mostly reflect equilibrium behavior, and only to a smaller extent the kinetics to reach the equilibrium state. It is well-known that there are two main relevant factors for the recrystallization process, thermodynamics and kinetics. 23 In this respect, it is interesting to note that a recent review indeed suggested that the molecular mobility (rather than thermodynamic quantities) appears to be the most important factor governing the crystallization rate. 24 It is also recognized that the complexity of the problem makes difficult, at present, the establishment of clear correlations between molecular mobility and physical stability, mainly due to the complexity of the involved molecular entities and their inter-and intramolecular interactions as well as due to the different time scales involved in amorphous materials, not only the so-called 'global mobility' which refers to the structural relaxation (α-relaxation). As for the thermodinamical aspect of recrystallization, lowering the temperature of the supercooled liquid decreases the steady state nucleation and growth rates, but, according to the kinetics, it increases the liquid's viscosity which is responsible for delaying the recrystallization. 24 The problem is even more difficult because nucleation and growth are commonly simultaneous effects that cannot be set apart. suppresses neural activity and seizures, and is in fact the first antiepileptic drug that acts on metabolic pathways, mimicking the effect of ketogenic diets used in drug-resistant epilepsy.
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Given the low solubility of STP in water, it might be interesting if its amorphous phase could be stabilized to improve its dissolution rate in the body and hence its bioavailability, while avoiding crystallization. In this contribution, we study the molecular dynamics and isother- 
where ∆ = s − ∞ is the dielectric strength (equal to the step variation of , and
proportional to the density of the molecules taking part in the relaxation process), and ∞ and s are the high-frequency and static low-frequency limits of the real permittivity.
The HN exponents, a and b are related to the shape and symmetry of the relaxation time distribution, and lie within 0 and 1. The characteristic time τ at which the dielectric loss of each relaxation is maximum was obtained from the corresponding τ HN value and HN exponents according to:
A special case of the HN function (Eq. (1)) is the Cole-Cole function, which corresponds to the case that the symmetry parameter b is equal to 1, leading to symmetric relaxation peaks.
The second BDS experiment, designed to study the isothermal crystallization kinetics of STP, consisted in measuring the decrease of strength of the dielectric loss as a function of time during the crystallization of the supercooled material at different fixed temperatures.
To this end, the molten sample was placed inside a precooled cryostat at 233 K (about 13 K below T g ) and then the temperature was raised at a rate of 10 K/min until reaching the desired temperature of the experiment, (T e ). We measured the recrystallization at five different T e temperatures between 273 and 293 K in the frequency range from 10 2 to 10 6 Hz.
These dielectric measurements were carried out on the same sample, which was re-melted and re-vitrified prior to each experimental run.
In order to discard the existence of a possible polymorphism of STP at ambient pressure, STP samples were loaded at ambient conditions into a 0.5-mm-diameter Lindemann capillar, which could rotate around its axis during data collection in order to minimize the effect of preferential orientation. Three samples were measured: the as-provided crystalline powder (as received from the manufacturer), the supercooled liquid during the crystallization process, and a fully recrystallized sample. The first and last were measured at ambient temperature (300 K), while the second was studied at 273 K.
Results and discussion
Relaxation Dynamics The Arrhenius plot of the characteristic times (τ ) corresponding to α, β and γ relaxations, as obtained from the fitting procedure, is shown in Fig. 2 . The γ relaxation follows Arrhenius behavior with an activation energy E a = 23.5 ± 0.1 J/mol K. The β relaxation displays two different Arrhenius regimes with E a = 98.2 ± 0.2 J/mol K below T g , and E a = 249 ± 5 J/mol K above T g . The continuous line is the fit of τ α using the Vogel-Fulcher-Tammann equation:
were the prefactor τ 0 , the strength parameter D, and the Vogel -Fulcher temperature T V F are phenomenological parameters with the following values obtained from the fit:
line indicates the value of τ α which is conventionally taken to mark the glass transition temperature (Log(τ α ) = 2, i.e τ α = 100 s). The intersection of the VFT fit and this dashed line gives a glass transition temperature of T g = 246.2 ± 0.5 K. The inset of Fig. 2 (a) shows the calorimetry thermogram of STP, which was acquired upon heating from below T g , after previously cooling the sample from the molten state at a rate of 2K/min. The arrow indicates the onset T g value obtained from the two tangents (dashed lines), which is 248 ± 1 K, in agreement with the data obtained from the BDS data and with the previously reported T g value.
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Figure 2: Arrhenius plot of the primary (α, filled green circles) and secondary (β, purple triangles and γ, blue empty circles) relaxation times, as extracted from the loss spectra displayed in Fig.1 . The continuous green line is the fit of τ α using the Vogel-Fulcher-Tammann equation (Eq. 3 ). The horizontal dashed line indicates the glass transition temperature. Pink asterisks portray the values obtained for τ β using the Coupling model (see text).
39,40
Inset: Differential scanning calorimetry thermogram acquired upon heating from the glass. The arrow indicates the onset T g value obtained from the two tangents shown with dashed lines.
In agreement with the VFT model, T V F is lower than T g . The VFT temperature dependence confirms that the slower (α) relaxation has a cooperative nature, which becomes more pronounced when approaching the glass transition, which is a typical feature of correlated glass forming systems.
The experimental value obtained for STP is m = 93 ± 7, which indicates this drug is a fragile glass former.
The interpretation of secondary relaxations is not as straightforward as for the primary one; a secondary relaxation may relate either to intramolecular motions involving the displacement of polar side-groups, or else it may be a Johari-Goldstein relaxation. The latter type of process involves the whole molecule and can be interpreted as the single-molecule relaxation, precursor of the cooperative α-relaxation according to the Coupling model. 39, [42] [43] [44] [45] The change in Arrhenius temperature dependence of τ β at T g is a characteristic feature that indicates the β relaxation is a Johari-Goldstein process. 40 This is also confirmed by the validity of the Coupling Model according to which, the relaxation time τ CM of the Johari-Goldstein relaxation should be related to that of the primary process τ α as:
Here t c 's typical value is 2 · 10 −12 s and represents a cross-over time determined by the intermolecular interaction and independent of temperature. 40, 46 The parameter p is equal to 1−β KW W , where β KW W is the stretched exponent that describes the shape of the α-relaxation process in the time domain. 47 For the obtained shape parameters (a, b) of the HN function employed to fit the primary relaxation, the following relation holds:
We have calculated the corresponding time τ CM with Eq. 5 and plotted the results in the Arrhenius plot shown in Fig. 2 (pink asterisks) . The calculated Coupling Model values are virtually identical to the experimental ones. Hence, the β relaxation can be considered the precursor of the α process and it is a whole-molecule process. Consequently, the observed γ process must be an intramolecular process, linked to the dynamics of a subpart or side-group of the non-rigid STP molecule.
Crystallization kinetics
In order to characterize the crystallization process from the supercooled liquid state into the stable crystalline state, we performed experiments at five fixed temperatures (T e ) above It can be observed that the recrystallization process produces a decrease in the intensity of the α relaxation peak, in the imaginary part of the dielectric permittivity, and correspondingly a decrease of static permittivity s , and thus of the dielectric strength in the real part. Fig. 4 shows the values of s at 100 Hz, during isothermal crystallization at T e = 278.0 K.
The plateau at long times indicates full crystallization of the sample. The inset to Fig. 4 shows a zoom-in at short times, where the intersection of two tangents marks the crystallization onset at time t o . In each series of isothermal spectra, the static permittivity was taken to be the value of the real permittivity at a fixed frequency varying between 10 2 and 10 4 Hz depending on the measuring temperature, but always representing the low-frequency plateau value of the real permittivity. To analyze the crystallization kinetics of STP, we have studied the time evolution of the normalized static-permittivity difference, as defined by D'Amore et al.:
Here, s (SL) and s (C) are the static permittivity of the supercooled liquid and the crystalline phase, respectively. The first value can be obtained by extracting s at time zero (right after supercooling), and the second by doing the same thing at the end of the crystallization process, where the sample is completely crystalline and no further change is observed in s (See Fig.4 ). s (t) is the static permittivity of the mixed-phase sample as a function of the time elapsed from the start of the isothermal measurements. There is a clear correlation between the two times in all cases. A linear regression gives for STP a slope value of (0.86 ± 0.07), whereas that reported for indomethacin and celecoxib is 0.8 ± 0.1. Interestingly, the experimental range of the slopes overlap, suggesting a possible universal slope value, at least above T g . Nevertheless, further substances should be studied to be able to postulate a possible general model that could predict t c for a given τ α . It is also interesting to note that the dependence of t c on τ α is sublinear.
If the temporal dependence of the crystallization were Avrami-like, 52,53 then the normalized static-permittivity difference would follow:
where K is the temperature-dependent crystallization rate and n is the Avrami exponent, which should be a constant that depends exclusively on the crystalline morphology and Figure 6 : Plots of characteristic crystallization time (t c ) versus average α relaxation time above T g in STP (circles), indomethacin (triangles) and celecoxib (squares). Values for indomethacin and celecoxib were obtained from reference. 31 Error bars are provided when n = 3; otherwise, the crystallization time is the average of two determinations. crystallization mechanism.
55 Fig. 7 (a) displays the Avrami plot at all studied temperatures.
The normalized static-permittivity differenceˆ is shown as a function of the time elapsed from the crystallization onset (t − t o ) for each crystallization temperature. The inset shows the Arrhenius plot of the onset time, t o . If the Avrami law were obeyed, each isothermal curve should look like a straight line, with constant slope equal to n. However, this is clearly not the case in Fig. 7(a) . To better visualize this fact, in Fig. 7(b) we have plotted the value of the effective (time-dependent) Avrami exponent for the temperature at which crystallization is slowest (namely, 273.0 K), defined as:
As It is evident form Fig. 7(b) that the Avrami exponent is far from constant. In order to unambiguously state that the Avrami's law is not followed by this compound the errors affecting the data have been calculated using a block average technique. As it can be seen in Fig. 7 the variation of the curve is greater than the calculated errors, supporting again that Avrami's law is not followed. The inset in the same figure shows a curve obtained by the subtraction of a linear curve to the experimental one in order to investigate if the exponent is constant or not in the most straightforward way. Again, the points seem not to follow an Avrami law, taking into account the obtained errors. Finally we have investigated if a different choice of t o could be possibly causing the variations on the Avrami exponent.
However t o is only affecting an horizontal and vertical displacement of the curve of Fig. 7(b) and, thus, it cannot cause a deviation from linearity in Fig. 7(b) . At higher isothermal crystallization temperature, the effective Avrami coefficient is observed to vary between 1 and 2 (not shown). A value in this range would suggest a one-dimensional crystallization of STP into needle-like crystallites, 56 which is however not observed (see below). It is worth pointing out that similar departures from the Avrami law have been observed also in other compounds.
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To understand the reason underlying the failure of the Avrami law we performed diffraction experiments and observations of the crystallization process with an optical microscope.
One possible cause of failure of the Avrami law, could be the existence of different polymorphs of STP, leading to the formation of crystallites with distinct structures and morphology, for example, as it happens for many pharmaceutical compounds. [58] [59] [60] [61] [62] [63] This possibility is discarded by our X-ray diffraction measurements. Fig. 8 shows the diffractograms obtained at (300 ± 1) K on the as-stored crystalline material, at (273 ± 1) K right after quenching from liquid state and at (300 ± 1) K after reheating.
It can be observed that the initial and recrystallized material display the same structure, and that the supercooled sample is indeed of glassy nature, as evidenced by the broad amorphous background. Within this broad feature, some crystalline Bragg reflections can be observed at 2θ = 6, 15.6, 15.9, 18.8 and 19.1. These correspond to the presence of a fraction of crystalline material. This behavior coincides with that observed by optical microscopy on molten drops at ambient temperature: while some drops recrystallized within approximately 10 minutes, some others remained liquid for much longer times. Fig. 9 shows of the crystallization of pure STP as observed with an optical microscope. 
Conclusions
By studying Stiripentol (STP) in its supercooled liquid and glass state, three different relaxations were identified: the α relaxation peak, corresponding to the collective reorientation of the STP molecules, a Johari Goldstein β relaxation that is the precursor of the α process according to the Coupling model, and a γ relaxation which corresponds to an intramolecu-lar relaxation. The T g of the material was determined both by dielectric spectroscopy and calorimetry, obtaining T g = 246.2 ± 0.5 K and T g = 248 ± 1 K, respectively.
Isothermal crystallization of STP was studied at temperatures between 273.0 and 293.0 K. It is found that the Avrami law is not obeyed. This happens because STP has difficulties when nucleating, and possibly also because the crystalline phase grows in a fractal 3D morphology.
It appears that supercooled liquid STP requires in general relatively high temperatures to produce a crystalline nucleus, from which crystal growth proceeds so fast, that no other nucleation site is generated during crystallization of a given liquid domain. As observed by means of X-ray diffraction, the initial solid and the recrystallized material display the same structure, which indicates that no other polymorph of STP appears at ambient pressure.
A sublinear correlation is found between the characteristic crystal-growth time and the collective relaxation dynamics. This correlation was observed also in other substances, and suggests a general correlation at temperatures above T g to predict a substance's crystalliza- 
